Oldham Rk
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 14
- Lung Cancer Research Studies 3
- Cytokine Signaling Pathways and Interactions 3
-
- Cancer Research and Treatments 6
- Co-authors
- Greco Fa (7 shared papers)Richardson Rl (5 shared papers)Leslie Burnett (1 shared paper)R B Herberman (6 shared papers)A E Maluish (2 shared papers)Richard D. Leavitt (1 shared paper)Thelma M. Watson (1 shared paper)West Wh (2 shared papers)
- Journals
- Seminars in Oncology (1 paper)PubMed (37 papers)
- Partner nations
- United States
In The Last Decade
Oldham Rk
36 papers receiving 563 citations
Peers
Comparison fields: 5 of 79
- Oncology 302
- Reproductive Medicine 87
- Immunology 171
- Radiology, Nuclear Medicine and Imaging 103
- Pathology and Forensic Medicine 73
Countries citing papers authored by Oldham Rk
This map shows the geographic impact of Oldham Rk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oldham Rk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oldham Rk more than expected).
Fields of papers citing papers by Oldham Rk
This network shows the impact of papers produced by Oldham Rk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oldham Rk. The network helps show where Oldham Rk may publish in the future.
Co-authors
The 20 scholars most cited alongside Oldham Rk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Advanced ovarian cancer: brief intensive combination chemotherapy and second-look operation. | 1981 | 89 |
| 2 | Small cell lung cancer: progress and perspectives. | 1978 | 89 |
| 3 | Biologicals and biological response modifiers: fourth modality of cancer treatment. | 1984 | 56 |
| 4 | Treatment of Ewing's sarcoma with adriamycin (NSC-123127). | 1972 | 48 |
| 5 | Gamma-interferon: physiology and speculation on its role in medicine. | 1987 | 48 |
| 6 | Tumor products and potential markers in small cell lung cancer. | 1978 | 43 |
| 7 | Immunotherapy: the old and the new. | 1983 | 36 |
| 8 | Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer. | 1982 | 22 |
| 9 | A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer. | 1984 | 21 |
| 10 | Immunologic monitoring in carcinoma of the breast. | 1977 | 20 |
| 11 | Natural killer cells: history, relevance, and clinical applications. | 1990 | 19 |
| 12 | Biology of cancer therapy: some new insights into adjuvant treatment of metastatic solid tumors. | 1983 | 18 |
| 13 | Monoclonal antibody therapy in malignant melanoma: factors effecting in vivo localization. | 1987 | 18 |
| 14 | Interferon as a biological response modifying agent in clinical trials. | 1983 | 17 |
| 15 | Continuous infusion interleukin-2 and tumor-derived activated cells as treatment of advanced solid tumors: a National Biotherapy Study Group Trial. | 1991 | 15 |
| 16 | Effects of recombinant interferon-alpha on immune function in cancer patients. | 1983 | 14 |
| 17 | Poorly differentiated neoplasms and tumors of unknown origin: introduction. | 1982 | 11 |
| 18 | A trial of autologous plasma perfusion over protein A in patients with breast cancer. | 1984 | 11 |
| 19 | Biologicals: new horizons in pharmaceutical development. | 1983 | 10 |
| 20 | Changes in immune function in patients receiving natural leukocyte interferon. | 1983 | 10 |
About Oldham Rk
Oldham Rk is a scholar working on Oncology, Biotechnology, Radiology, Nuclear Medicine and Imaging, Immunology and Emergency Medicine, having authored 38 papers that have together received 688 indexed citations. Recurring topics across this work include Cancer Research and Treatments (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Lung Cancer Research Studies (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Immunotherapy and Immune Responses (3 papers), Hematological disorders and diagnostics (3 papers), Immune Cell Function and Interaction (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Oncology (302 citations), Reproductive Medicine (87 citations), Immunology (171 citations), Radiology, Nuclear Medicine and Imaging (103 citations) and Pathology and Forensic Medicine (73 citations). Oldham Rk has collaborated with scholars based in United States. Frequent co-authors include Greco Fa, Richardson Rl, Leslie Burnett, R B Herberman, A E Maluish, Richard D. Leavitt, Thelma M. Watson, West Wh, Rebecca Jeffries Birch and Lynn E. S̄pitler. Their work appears in journals such as Seminars in Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.